Record mula sa primary source

Decision-gradePag-apruba ng FDA

Gilead Sciences Inc · Pinahintulutan ng FDA ang Hepcludex (bulevirtide-gmod)

FDA's Purple Book lists BLA 761468 (Hepcludex, bulevirtide-gmod; Gilead Sciences, Inc., CDER) as licensed on 2026-05-22.

Mahahalagang fact

Na-file: May 22, 2026, 12:00 AM
Kaganapan: Pag-apruba ng FDA
Direksyon: Positibo
Kumpanya: GILDGilead
Asset: Hepcludex
Pinagmulan: Pinagmulan
Kumpiyansa: May source